Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTNK-tPA vs Alteplase in Acute Ischemic Stroke (TRACE II)
NCT04797013Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jun 2021
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jun 2021; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04797013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797013.